CTRI/2023/11/060217尚未招募2 期
Pharmaceutical Analytical study of modified dosage forms of Rakshognadilepa and cream and its comparative clinical evaluation in mukhadushika( Acne vulgaris)- A randomized controlled trial - nil
Dr Neha Lidbe0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients presenting with signs and symptoms like pain, burning, itching of Mukhdushika
- •(Acne vulgaris) as told under classical texts will be selected.
- •2 Patients of the age group between 15-35 years will be selected irrespective of sex and
- •economical status.
- •3 Skin rash or lesion on the face, truck (chest) neck, back, or other area - Comedones
- •(whiteheads or blackheads) Pustules , Cysts , Papules ,Redness (erythema) of the skin
- •lesions or skin around a lesion - Inflammation around the skin eruptions - Crusting of
- •skin eruptions , Scarring of the skin
- •4 Diagnosis will be made on the cardinal signs and symptoms of Mukhdushika .
- •5 Acne vulgaris) as explained in the classics. - Pidika - Daha - Shool – Kandu
排除标准
- •The age group < 15 years and > 35 years.
- •2. Patients unfit for treatment.
- •3. Acne vulgaris other than face region i.e. chest & back.
- •4. Mukhdushika with other systemic disorder like anemia, hemophilia etc.
研究者
相似试验
尚未招募
3 期
Comparative clinical efficacy of Varun Twak Lepa and Krushnatiladi Lepa in Vyanga(Melasma)CTRI/2023/12/060971Dr Pratiksha Mahure
已完成
不适用
Study on pharmacokinetics and dosage adaptation of meropenem in pediatric patients receiving continuous hemodiafiltratioInfectious diseasesJPRN-UMIN000014904Department of clinical pharmacology and genetics, school of pharmaceutical science, university of Shizuoka graduate school70
进行中（未招募）
不适用
Pharmacodynamic and clinical evaluation of dose and taste-optimised low volume PEG-based bowel cleansing solutions using the split-dosing intake regimen in healthy subjects and in subjects undergoing screening colonoscopyBowel cleansing prior to colonoscopyMedDRA version: 14.1Level: PTClassification code 10066943Term: Bowel preparationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-003052-37-DEorgine Ltd
已完成
不适用
nderstanding drug concentrations in the body on the optimisation of sexually transmitted infections (STIs) treatments.Anorectal Chlamydia trachomatis (CT)Oropharyngeal Chlamydia trachomatis (CT)Anorectal Neisseria gonorrhoeae (NG)Oropharyngeal Neisseria gonorrhoeae (NG)Infection - Sexually transmitted infectionsACTRN12621000339853niversity of Melbourne60
进行中（未招募）
1 期
A research study to learn about the effects of IMB-1018972, to try and help your heart cell use energy more efficiently, to find the best dose, and to see how safe it is. This is for patients who may be at risk for a heart condition known as diabetic cardiomyopathy (DbCM) as a complication of a type 2 diabetes mellitus (T2DM).EUCTR2020-003280-26-GBImbria Pharmaceuticals, Inc.36